Can GAVI’s New Partnership Model Crack ‘mhealth Pilotitis’ While Opening New Markets For Vodafone?

Stephanie Hanson | | August 21, 2013

In the 13 years since it was founded to jumpstart stagnating global vaccination rates, the GAVI Alliance has achieved some remarkable results.

Three hundred and seventy million children in the world’s poorest countries have been immunized with support from GAVI, formerly known as the Global Alliance for Vaccines and Immunisations. These relatively low-cost immunizations have prevented over 5.5 million future deaths. 

GAVI has achieved these results through partnerships with donor governments, developing countries and development organizations including UNICEF, the World Bank and the Gates Foundation. In addition, it has worked collaboratively with the pharmaceutical industry to help estalish prices that are affordable for developing countries, including through an unusual mechanism it calls an “advance market commitment.” Pharmaceutical companies like GlaxoSmithKline and Pfizer make a multi-year commitment to provide the vaccines at the set price.

This partnership model has enabled the delivery of millions of low-cost vaccines into developing countries – and demonstrated how multinationals can be incentivized to tackle major development challenges.